Dayle,
Quote:
Does anyone know what happened to the price during the safety review period? Did it go up or down when it was re-released here?
Thanks dayle!
|
When Tysabri was being reviewed for those approx 18 months, readers on other forums stated that the CRAB drug makers raised the price of their drugs. I can't confirm this but perhaps someone else may be able to.
I do know that Biogen raised the wholesale cost of Tysabri by 22% during this period!!! That means the cost to the clinics would be about $ 2200.00 per infusion..and that's just their cost of buying it from Biogen. I suspect the cost per infusion is going to be around $3000.00 - $ 4500.00 based on what patients were charged the first time around. The large variance is due to the different charges for administering the Tysabri at each clinic.
It certainly won't be cheap...I'm guessing that the yearly cost will average out at around $ 40,000.00!
Harry